Antipsychotic drugs prescribed to children and adolescents with disruptive behaviors, such as ADHD, schizophrenia or bipolar disorder, can cause Type 2 diabetes and obesity....
According to a joint statement by the American Diabetes Association and the European Association for the Study of Diabetes about the safety and efficacy...
Engineers are using additive manufacturing to create an improved type of glucose sensor for diabetes patients. It will become part of a system that...
Majority of those surveyed expressed an interest in a peer mentoring program to improve diabetes control.
Starting from human skin cells, researchers have created human insulin-producing cells that respond to glucose and correct blood-sugar levels.
People with type 1 diabetes who intensively control their blood glucose (blood sugar) early in their disease are likely to live longer than those who do not.
About one-third of type 1 diabetics (T1D) produce insulin even upward of forty years from initial diagnosis, according to a new study.
Type 1 diabetics who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation.
Researchers announced that they have made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes.
Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with Type 1 diabetes, according to new research.
Study finds that a peptide called caerulein can convert existing cells in the pancreas into those cells destroyed in type 1 diabetes-insulin-producing beta cells.
Research has revealed two new genetic causes of neonatal diabetes.
The latest approach to islet transplantation has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
The FDA is working with Nova Diabetes Care to recall 21 lots of glucose test strips marketed under the brand names Nova Max Blood Glucose Test Strips and Nova Max Plus Glucose Meter Kits. The test strips under recall may report a false, abnormally high blood glucose result.
Adding certain foods to the diets of youth with Type 1 diabetes kept them producing some of their own insulin for up to two years after diagnosis.